Dr. Felix Weiland, Boehringer Ingelheim microParts GmbH - Qepler Summits And Conferences

Dr. Felix Weiland

Head of Product & Process Technology
Boehringer Ingelheim microParts GmbH
Gütersloh, Germany
 Boehringer Ingelheim ist ein weltweit tätiges, forschendes Pharmaunternehmen, bei dem Menschen aus vielen verschiedenen Kulturen zusammenarbeiten.

Felix is a pharmacist by training with a PhD in pharmacology.

In 2006, he joined Boehringer Ingelheim as a trainee, focusing on launch and transfer activities of inhalative products. He then took over different roles at BI microParts in Dortmund at the development site of inhalation devices as development QA manager, senior project manager, and lab head of device development.

In 2010, he joined the Ger-resheimer Group at Bünde as a QC head and later as quality director. Buende is a large-scale manufacturing site of sterile primary packaging components, i.e.RTF®- syringes and insulin cartridges.

In 2015, he returned to Boehringer Ingelheim to implement systems for systematic life cycle management of the Respimat® Plat¬form Technology, including ownership of the design history files.

Currently he is the director of product- & process-technology including responsibilities for project management, design verification laboratories, clinical trial supply, and design & process technology of devices.

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 23 May 2019
  • Berlin, DE
  • Pharma
Day 1: Thursday, 23 May 2019
BLOCK: FORMULATION, DEVELOPMENT & DESIGN.
CASE STUDY: TO BE ANNOUNCED.
View Details